Revolution Medicines (RVMD) FCF Margin (2019 - 2023)
Revolution Medicines' quarterly FCF Margin came in at 16421.16% in Q4 2023, down 1606064.0% year-on-year from N/an in Q4 2022, and down 820.2% quarter-over-quarter from 1784.52% in Q2 2023.
Revolution Medicines has reported FCF Margin for 5 years, with the latest figure at 16421.16% in Q4 2023.
- For the quarter ending Q4 2023, FCF Margin fell 1606064.0% year-over-year to 16421.16%; the trailing twelve-month figure through Sep 2024 stood at 74134.37% (down 7303912.0% YoY), and the FY2023 full-year result was 3049.94%, down 241167.0% from the prior year.
- FCF Margin for Q4 2023 stood at 16421.16%, down from 1784.52% in the prior quarter.
- The five-year high for FCF Margin was 97.44% in Q4 2019, with the low at 16421.16% in Q4 2023.
- Average FCF Margin over 5 years is 1497.75%, with a median of 376.35% recorded in 2021.
- Year-over-year, FCF Margin surged 161463 bps in 2022 and sank 1606064 bps in 2023.
- Tracing RVMD's FCF Margin over 5 years: stood at 97.44% in 2019, then slumped by 210 bps to 301.75% in 2020, then sank by 60 bps to 483.6% in 2021, then gained by 25 bps to 360.52% in 2022, then slumped by 4455 bps to 16421.16% in 2023.
- The last three FCF Margin figures came in at 16421.16% (Q4 2023), 1784.52% (Q2 2023), and 914.59% (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -16,421.16% |
| Jun 30, 2023 | -1,784.52% |
| Mar 31, 2023 | -914.59% |
| Dec 31, 2022 | -360.52% |
| Sep 30, 2022 | -1,690.91% |
| Jun 30, 2022 | -624.99% |
| Mar 31, 2022 | -749.96% |
| Dec 31, 2021 | -483.60% |
| Sep 30, 2021 | -3,305.54% |
| Jun 30, 2021 | -384.42% |
| Mar 31, 2021 | -376.35% |
| Dec 31, 2020 | -301.75% |
| Sep 30, 2020 | -212.72% |
| Jun 30, 2020 | -198.68% |
| Mar 31, 2020 | -247.89% |
| Dec 31, 2019 | -97.44% |
| Sep 30, 2019 | -105.56% |
| Jun 30, 2019 | -98.29% |
| Mar 31, 2019 | -98.33% |